Acitretin Capsules   3

Background
The Department of Veterans Affairs (VA) and the Department of Defense (DOD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor (PPV) Programs. The purpose of this solicitation is to establish a supply source that will provide the drugs listed in the schedule for purchase through the PPV Programs. The total annual estimated usage for VA, Federal Health Care Center (FHCC), State Veterans Homes - Option 2 (SVH), DOD, Indian Health Service (IHS), and Bureau of Prisons (BOP) appears on the Schedule of Supplies section of this Solicitation.

Work Details
The contract is for the supply of Acitretin Capsules. The contractor is required to provide specific quantities of Acitretin Capsules in different strengths (10MG, 17.5MG, and 25MG) for the base year and all four option years. Offered prices must include a Cost Recovery Fee of 0.5% and an 11-digit National Drug Code (NDC) number unique to the offeror's company. The contract will be effective on the date the government signs the SF1449 and notifies the offeror of award.

Period of Performance
The Implementation Period begins on the Contract Effective Date and ends at the start of the Ordering Period, with a maximum duration of 60 days if awarded after October 10, 2022. The base year Ordering Period will be in effect for one year.

Place of Performance
Products will be ordered by government Prime Vendor contractors from the awarded contractor and delivered to various authorized facilities including all Department of Veterans Affairs (VA) facilities, all Ordering Activities under the Department of Defense (DOD) Pharmaceutical Prime Vendor Program, all Indian Health Service (IHS) facilities, all Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.